Current status of genome editing in vector mosquitoes: A review

BioScience Trends

Volumn 10, Issue 6, 2016, Pages 424-432

  Reegan, Appadurai Daniel ^a,b   Ceasar, Stanislaus Antony ^a   Paulraj, Michael Gabriel ^a   Ignacimuthu, Savarimuthu ^a,c   Al Dhabi, Naif Abdullah ^d  

^a LOYOLA COLLEGE   (India)

^b MADRAS CHRISTIAN COLLEGE   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Clustered regulatory interspaced short palindromic repeats (CRISPR) CRISPR associated protein 9 (Cas9); Gene alteration; Mosquito borne disease control; Transcription activator like effector nuclease (TALEN); Zinc finger nuclease (ZFN)

Indexed keywords

ANIMAL; GENE EDITING; GENETICS; HUMAN; INSECT VECTOR; MOSQUITO;

ANIMALS; CULICIDAE; GENE EDITING; HUMANS; INSECT VECTORS;

EID: 85011117102     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2016.01180     Document Type: Review

References (74)

1. Reegan AD, Gandhi MR, Paulraj MG, Balakrishna K, Ignacimuthu S. Effect of niloticin, a protolimonoid isolated from Limonia acidissima L.(Rutaceae) on the immature stages of dengue vector Aedes aegypti L.(Diptera: Culicidae). Acta Trop. 2014; 139:67-76
2. WHO. World malaria report. World Health Organization. http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/2014 (accessed September 22, 2016)
3. WHO. WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome. http://www.who.int/mediacentre/news/statements/2016/emergencycommittee-zika-microcephaly/en/2016 (accessed September 22, 2016)
4. Bayen S. Occurrence, bioavailability and toxic effects of trace metals and organic contaminants in mangrove ecosystems: A review. Environ Int. 2012; 48:84-101
5. Madhu SK, Shaukath AK, Vijayan VA. Efficacy of bioactive compounds from Curcuma aromatica against mosquito larvae. Acta Trop. 2010; 113:7-11
6. Tikar S, Kumar A, Prasad G, Prakash S. Temephosinduced resistance in Aedes aegypti and its crossresistance studies to certain insecticides from India. Parasitol Res. 2009; 105:57-63
7. Catteruccia F, Nolan T, Loukeris TG, Blass C, Savakis C, Kafatos FC, Crisanti A. Stable germline transformation of the malaria mosquito Anopheles stephensi. Nature. 2000; 405:959-962
8. Coates CJ, Jasinskiene N, Miyashiro L, James AA. Mariner transposition and transformation of the yellow fever mosquito, Aedes aegypti. Proc Natl Acad Sci. 1998; 95:3748-3751
9. Grossman GL, Rafferty CS, Clayton JR, Stevens TK, Mukabayire O, Benedict MQ. Germline transformation of the malaria vector, Anopheles gambiae, with the piggyBac transposable element. Insect Mol Biol. 2001; 10:597-604
10. Jasinskiene N, Coates CJ, Benedict MQ, Cornel AJ, Rafferty CS, James AA, Collins FH. Stable transformation of the yellow fever mosquito, Aedes aegypti, with the Hermes element from the housefly. Proc Natl Acad Sci. 1998; 95:3743-3747
11. Gabrieli P, Smidler A, Catteruccia F. Engineering the control of mosquito-borne infectious diseases. Genome Biol. 2014; 15:1-9
12. Knipling E. Possibilities of insect control or eradication through the use of sexually sterile males. J Econ Entomol. 1955; 48:459-462
13. Aryan A, Anderson MAE, Myles KM, Adelman ZN. TALEN-based gene disruption in the dengue vector Aedes aegypti. Plos One. 2013; 8:e60082
14. DeGennaro M, McBride CS, Seeholzer L, Nakagawa T, Dennis EJ, Goldman C, Jasinskiene N, James AA, Vosshall LB. orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET. Nature. 2013; 498:487-491
15. Smidler AL, Terenzi O, Soichot J, Levashina EA, Marois E. Targeted mutagenesis in the malaria mosquito using TALE nucleases. PLoS One. 2013; 8:e74511
16. Criscione F, O'Brochta DA, Reid W. Genetic technologies for disease vectors. Curr Opin Insect Sci. 2015; 10:90-97
17. Bibikova M, Beumer K, Trautman JK, Carroll D. Enhancing gene targeting with designed zinc finger nucleases. Science. 2003; 300:764-764
18. Bibikova M, Golic M, Golic KG, Carroll D. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics. 2002; 161:1169-1175
19. Boch J, Bonas U. Xanthomonas AvrBs3 familytype III effectors: Discovery and function. Annu Rev Phytopathol. 2010; 48:419-436
20. Curtin SJ, Zhang F, Sander JD, Haun WJ, Starker C, Baltes NJ, Reyon D, Dahlborg EJ, Goodwin MJ, Coffman AP, Dobbs D, Joung JK, Voytas DF, Stupar RM. Targeted mutagenesis of duplicated genes in soybean with zinc-finger nucleases. Plant Physiol. 2011; 156:466-473
21. Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, Pierick CJ, Hoffman E, Maeder ML, Khayter C, Reyon D, Dobbs D, Langenau DM, Stupar RM, Giraldez AJ, Voytas DF, Peterson RT, Yeh JR, Joung JK. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods. 2011; 8:67-69
22. Shukla VK, Doyon Y, Miller JC, DeKelver RC, Moehle EA, Worden SE, Mitchell JC, Arnold NL, Gopalan S, Meng X, Choi VM, Rock JM, Wu YY, Katibah GE, Zhifang G, McCaskill D, Simpson MA, Blakeslee B, Greenwalt SA, Butler HJ, Hinkley SJ, Zhang L, Rebar EJ, Gregory PD, Urnov FD. Precise genome modification in the crop species Zea mays using zincfinger nucleases. Nature. 2009; 459:437-441
23. Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M, Voytas DF, Long CR, Whitelaw CBA, Fahrenkrug SC. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci. 2012; 109:17382-17387
24. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011; 39:e82
25. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337:816-821
26. Carroll D. Genome Engineering with Zinc-Finger Nucleases. Genetics. 2011; 188:773-782
27. Callaway E. Mosquitoes engineered to pass down genes that would wipe out their species. Nature | News 2015
28. Ledford H, Callaway E. Gene drive' mosquitoes engineered to fight malaria. Nature | News. 2015
29. Overcash JM, Aryan A, Myles KM, Adelman ZN. Understanding the DNA damage response in order to achieve desired gene editing outcomes in mosquitoes. Chromosome Res. 2015; 23:31-42
30. Champer J, Buchman A, Akbari OS. Cheating evolution: Engineering gene drives to manipulate the fate of wild populations. Nat Rev Genet. 2016; 17:146-159
31. Adelman ZN, Tu Z. Control of mosquito-borne infectious diseases: Sex and gene drive. Trends Parasitol. 2016; 32:219-229
32. Chakradhar S. Buzzkill: Regulatory uncertainty plagues rollout of genetically modified mosquitoes. Nat Med. 2016; 21:416-418
33. Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, Chandrasegaran S. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol. 2001; 21:289-297
34. Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci. 1996; 93:1156-1160
35. Miller J, McLachlan AD, Klug A. Repetitive zincbinding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 1985; 4:1609-1614
36. Wolfe SA, Nekludova L, Pabo CO. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophy Biomol Struct. 2000; 29:183-212
37. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. FLASH assembly of TALENs for highthroughput genome editing. Nat Biotechnol. 2012; 30:460-465
38. Mussolino C, Cathomen, T. TALE nucleases: Tailored genome engineering made easy. Curr Opin Biotechnol. 2012; 23:644-650
39. Sakuma T, Woltjen K. Nuclease-mediated genome editing: At the front-line of functional genomics technology. Dev Growth Differ. 2014; 56:2-13
40. Grissa I, Vergnaud G, Pourcel C. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics. 2007; 8:1-10
41. Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014; 346):1-9
42. Barrangou R, Dounda JA. Applications of CRISPR technologies in research and beyond. Nat Biotech. 2016; 34:933-941
43. Ceasar A, Rajan V, Prykhozhij SV, Berman JN, Ignacimuthu S. Insert, remove or replace: A highly advanced genome editing system using CRISP/Cas9 BBA Mol Cell Res. 2016; 1863:2333-2344
44. Franz AW, Clem RJ, Passarelli AL. Novel genetic and molecular tools for the investigation and control of dengue virus transmission by mosquitoes. Curr Trop Med Rep. 2014; 1:21-31
45. Liesch J, Bellani LL, Vosshall LB. Functional and genetic characterization of neuropeptide Y-like receptors in Aedes aegypti. PLoS Negl Trop Dis. 2013; 7:e2486
46. McMeniman CJ, Corfas RA, Matthews BJ, Ritchie SA, Vosshall LB. Multimodal integration of carbon dioxide and other sensory cues drives mosquito attraction to humans. Cell. 2014; 156:1060-1071
47. Aryan A, Myles KM, Adelman ZN. Targeted genome editing in Aedes aegypti using TALENs. Methods. 2014; 69:38-45
48. Kistler KE, Vosshall LB, Matthews BJ. Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. Cell Reports. 2015; 11:51-60
49. Basu S, Aryan A, Overcash JM, Samuel GH, Anderson MAE, Dahlem TJ, Myles KM, Adelman ZN. Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti. Proc Natl Acad Sci. 2015; 112:4038-4043
50. Dong S, Lin J, Held NL, Clem RJ, Passarelli AL, Franz AW. Heritable CRISPR/Cas9-mediated genome editing in the yellow fever mosquito, Aedes aegypti. Plos One. 2015; 10:e0122353
51. Hall AB, Basu S, Jiang X, Qi Y, Timoshevskiy VA, Biedler JK, Sharakhova MV, Elahi R, Anderson MA, Chen XG, Sharakhov IV, Adelman ZN, Tu Z. A maledetermining factor in the mosquito Aedes aegypti. Science. 2015; 348:1268-1270
52. Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E, James AA. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci. 2015; 112:E6736-E6743
53. Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C, Katsanos D, Gribble M, Baker D, Marois E, Russell S, Burt A, Windbichler N, Crisanti A, Nolan T. A CRISPRCas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol. 2016; 34:78-83
54. Galizi R, Hammond A, Kyrou K, Taxiarchi C, Bernardini F, O'Loughlin SM, Papathanos PA, Nolan T, Windbichler N, Crisanti A. A CRISPR-Cas9 sex-ratio distortion system for genetic control. Scientific Reports. 2016; 6:1-5
55. Briese DT. Weed biological control: Applying science to solve seemingly intractable problems. Aust J Entomol. 2004; 43:304-317
56. Esvelt KM, Smidler AL, Catteruccia F, Church GM. Concerning RNA-guided gene drives for the alteration of wild populations. Elife. 2014; 3:e03401
57. Cradick TJ, Fine EJ, Antico CJ, Bao G. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 2013; 41:9584-9592
58. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013; 31:822-826
59. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science. 2013a; 339:823-826
60. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154:1380-1389
61. Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK. High-fidelity CRISPRCas9 nucleases with no detectable genome-wide offtarget effects. Nature. 2016; 529:490-495
62. Kim D, Bae S, Park J, Kim E, Kim S, Yu HR, Hwang J, Kim JI, Kim JS. Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods. 2015; 12:237-243
63. Vogel G. U.K. researcher receives permission to edit genes in human embryos. Science News. http://www.sciencemag.org/news/2016/02/uk-researcher-receivespermission-edit-genes-human-embryos (accessed September 22, 2016)
64. DeFrancesco L. Move over ZFNs. Nature Biotechnol. 2012; 29:681-684
65. Gaj T, Gersbach CA, Barbas CF. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013; 31:397-405
66. Ledford H. CRISPR, the disruptor. Nature. 2015; 522:20-24
67. Alphey L. Can CRISPR-Cas9 gene drives curb malaria? Nat Biotechnol. 2016; 34:149-150
68. Paulraj MG, Ignacimuthu S, Reegan AD. Gene silencing and gene drive in dengue vector control: A review. Indian J. Nat Prod Res. 2016; 7:1-8
69. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013; 31:827-832
70. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013b; 31:833-838
71. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013; 31:839-843
72. Burt A. Site-specific selfish genes as tools for the control and genetic engineering of natural populations. Proc Biol Sci. 2003; 270:921-928
73. Oye KA, Esvelt K, Appleton E, Catteruccia F, Church G, Kuiken T, Lightfoot SB, McNamara J, Smidler A, Collins JP. Regulating gene drives. Science. 2014; 345:626-628
74. Webber BL, Raghu S, Edwards OR. Opinion: Is CRISPR-based gene drive a biocontrol silver bullet or global conservation threat? Proc Natl Acad Sci. 2015; 112:10565-10567